Timur Bekmambetov may be in the midst of filming Abraham Lincoln: Vampire Hunter, but he's apparently not tired of undead monsters just yet. The Wanted director has won out in the competition to produce Maggie, a low-budget zombie flick penned by NASA satellite guidance system programmer, John Scott 3.
The estimated $4-8 million cost of Maggie was the big selling point for the project, which also offers a slightly different spin on the traditional zombie mythos by extending the incubation period of zombie infection out over a period of six months - as opposed to the instantaneous infection you see in most zombie flicks.
Deadline confirms that, like the now-delayed Apollo 18, Maggie will be a cheap production that features Bekmambetov as a producer only. Already onboard to direct the new zombie tale is art designer Henry Hobson, who was responsible for crafting the titles of recent films like Rango, The Karate Kid, Sherlock Holmes, and the Walking Dead TV series. Make of that what you will.
Maggie tells the story of the titular character, a 16-year-old middle-American girl who is bitten by a zombie, but is slowly turned into an undead creature herself over the course of half a year. The film will focus on Maggie's transformation and her family's attempts to cope with her inevitable fate.
So how many zombie movies are being actively developed again, you ask? Well, there's Pride and Prejudice and Zombies, Resident Evil 5, Warm Bodies, World War Z, Zombies Vs. Robots - not to mention the second season of The Walking Dead. That's not an inclusive list, but it's more than enough to illustrate that we're in the midst of a cinematic zombpocalypse.
I enjoy a good zombie movie as much as the next man (unless the next man is George A. Romero, I suppose), but this is pushing it. It makes sense that zombies would be more popular than ever - they do serve as a fitting metaphor for mindless consumption in modern society - but surely even the most die-hard (pun intended) undead fans have gotten their fill at this point...
Maggie is expected to move quickly into production sometime over the next year. We'll keep you posted on its status.
Leave A Comment
Looking for an AD FREE EXPERIENCE on ScreenRant?Get Your Free Access Now!